0001209191-20-047804.txt : 20200820 0001209191-20-047804.hdr.sgml : 20200820 20200820183655 ACCESSION NUMBER: 0001209191-20-047804 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200818 FILED AS OF DATE: 20200820 DATE AS OF CHANGE: 20200820 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Erbez Georgia CENTRAL INDEX KEY: 0001557930 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38800 FILM NUMBER: 201121104 MAIL ADDRESS: STREET 1: 6300 DUMBARTON CIRCLE CITY: FREMONT STATE: CA ZIP: 94555 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Harpoon Therapeutics, Inc. CENTRAL INDEX KEY: 0001708493 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 473458693 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 131 OYSTER POINT BOULEVARD STREET 2: SUITE 300 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-443-7400 MAIL ADDRESS: STREET 1: 131 OYSTER POINT BOULEVARD STREET 2: SUITE 300 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-08-18 0 0001708493 Harpoon Therapeutics, Inc. HARP 0001557930 Erbez Georgia C/O HARPOON THERAPEUTICS, INC. 131 OYSTER POINT BOULEVARD, SUITE 300 SOUTH SAN FRANCISCO CA 94080 0 1 0 0 Chief Financial Officer Common Stock 2020-08-18 4 P 0 2098 11.60 A 3915 I See footnote Common Stock 2020-08-19 4 P 0 5000 11.40 A 8915 I See footnote Common Stock 47292 D Common Stock 6700 I See footnote Shares indirectly held by Georgia Leigh Erbez Charles Schwab & Co Inc Cust IRA Contributory ("Georgia Erbez IRA Contributory"). The Reporting Person has beneficial ownership over these shares held by Georgia Erbez IRA Contributory. Shares indirectly held by David Milan Erbez Charles Schwab & Co Inc Cust IRA Contributory ("David Erbez IRA Contributory"). The Reporting Person has beneficial ownership over these shares held by David Erbez IRA Contributory. /s/ Georgia Erbez by Christopher Whitmore, Attorney-in-Fact 2020-08-20